-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Numerous studies have shown that infusion of human serum albumin solution (HAS) restores normal blood volume and improves arterial dilatation in patients with cirrhosis and has potential immunomodulatory or anti-inflammatory properties in hospitalized patients with complications of cirrhosis Therefore, albumin infusion is recommended by all international guidelines
Numerous studies have shown that infusion of human serum albumin solution (HAS) restores normal blood volume and improves arterial dilatation in patients with cirrhosis and has potential immunomodulatory or anti-inflammatory properties in hospitalized patients with complications of cirrhosis Therefore, albumin infusion is recommended by all international guidelines
Vascular Statistics Infection
The results of the study finally showed that the patient's end-stage liver disease score, white blood cell count, calprotectin level, CD163 level, tumor necrosis factor level, renin, and atrial natriuretic peptide levels were associated with increased 3-month mortality
This study found that, contrary to many preclinical studies, targeted intravenous albumin therapy in hospitalized decompensated cirrhosis had no effect on broad systemic inflammation, albumin function, cardiovascular mediators, and biomarkers compared with standard care , which is consistent with previous clinical findings
This study found that, contrary to many preclinical studies, targeted intravenous albumin therapy in hospitalized decompensated cirrhosis had no effect on broad systemic inflammation, albumin function, cardiovascular mediators, and biomarkers compared with standard care , which is consistent with previous clinical findings
Original source:
China, Louise.
China, Louise.
Et al.
Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis.
Clinical and Translational Gastroenterology.
2022.
Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis.
Leave a message here